[Retracted] Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes

Table 3

Incidence of biological markers of adverse events in patients on AS/AQ or AL during 28 days of followup.

Laboratory parameter	AS/AQ		AL
	𝑁	%	𝑁	%
Biochemistry
Bilirubin > 1 mg/dL	20/68	29.4	18/69	26.1
Alanine transaminase > 37 mg/dL	01/68	01.5	0	0
Creatinine > 11 mg/dL	0		01/69	01.4
Haematology
Anaemia (Hb < 9.5 g/dL)	23/68	33.8	21/69	30.4
Leucopenia (WBC < 5000/𝜇L)	12/68	17.6	13/69	18.8
Lymphopenia (lymph < 4.0)	10/68	14.7	10/69	14.5
Neutropenia (neutro < 1.5)	02/68	02.9	09/69	13.0
Platelets (platelets < 150∗10^3)	02/68	02.9	03/69	04.3